CDC ACIP met today on Covid-19 vaccines. They will not vote on a specific product recommendation until after FDA issues EUA. Here are a few takeaways from today& #39;s session on phased vaccine allocation when supply is limited. 1/

Phase 1 will include healthcare personnel (HCP), other essential workers, high risk adults, and adults over 65. Phase 1 has 3 tiers: 1a (highest priority), 1b and 1c.
2/

Workgroup proposed HCP and LTCF residents in phase 1a and essential workers in 1b. Members agreed w/ HCP as top priority, but differing views on LTCF res in 1a. Some concerned that vax efficacy/safety has not been studied in LTCF, but several others supported inclusion in 1a.
3/

Reasons given for including LTCF res in 1a:
https://abs.twimg.com/emoji/v2/... draggable="false" alt="➡️" title="Pfeil nach rechts" aria-label="Emoji: Pfeil nach rechts">High Covid-19 mortality. Vaccine will save lives even if VE in LTCF res is lower.
https://abs.twimg.com/emoji/v2/... draggable="false" alt="➡️" title="Pfeil nach rechts" aria-label="Emoji: Pfeil nach rechts">Efficiency of vaccinating staff and residents at same time.
https://abs.twimg.com/emoji/v2/... draggable="false" alt="➡️" title="Pfeil nach rechts" aria-label="Emoji: Pfeil nach rechts">We won& #39;t have more data on safety/efficacy in LTCF res by the time we reach phase 1c.
4/

There was broad support for inclusion of essential workers in phase 1b. Several members said this is critical to address health equity issues. 5/

The phases will be dynamic and overlapping. A new phase will begin as demand reaches saturation in the prior phase. More guidance is needed on subprioritization within phase 1a. States need more resources to implement this complex initiative.
End/